Compare LLY & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LLY | WFC |
|---|---|---|
| Founded | 1876 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 950.7B | 290.6B |
| IPO Year | N/A | N/A |
| Metric | LLY | WFC |
|---|---|---|
| Price | $1,072.60 | $89.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 15 |
| Target Price | ★ $1,104.11 | $94.75 |
| AVG Volume (30 Days) | 2.8M | ★ 12.2M |
| Earning Date | 02-04-2026 | 01-14-2026 |
| Dividend Yield | 0.64% | ★ 1.92% |
| EPS Growth | ★ 121.02 | 16.57 |
| EPS | ★ 20.44 | 6.26 |
| Revenue | $59,419,800,000.00 | ★ $80,041,000,000.00 |
| Revenue This Year | $42.86 | $11.84 |
| Revenue Next Year | $20.29 | $4.42 |
| P/E Ratio | $52.69 | ★ $14.95 |
| Revenue Growth | ★ 45.41 | 2.67 |
| 52 Week Low | $623.78 | $58.42 |
| 52 Week High | $1,133.95 | $97.76 |
| Indicator | LLY | WFC |
|---|---|---|
| Relative Strength Index (RSI) | 54.25 | 38.97 |
| Support Level | $1,058.00 | $93.65 |
| Resistance Level | $1,090.22 | $95.75 |
| Average True Range (ATR) | 27.11 | 1.79 |
| MACD | -3.31 | -0.71 |
| Stochastic Oscillator | 39.38 | 12.37 |
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Wells Fargo is one of the largest banks in the United States, with approximately $2.0 trillion in balance-sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US market.